Literature DB >> 23409849

Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007-2011.

Makoto Shiraki1, Shuhei Nishiguchi, Masaki Saito, Yoshitaka Fukuzawa, Toshihiko Mizuta, Masaki Kaibori, Tatsunori Hanai, Kayoko Nishimura, Masahito Shimizu, Hisashi Tsurumi, Hisataka Moriwaki.   

Abstract

AIM: Current guidelines recommended adequate nutritional support for patients with liver cirrhosis to improve clinical outcome and quality of life (QOL). However, these evidences were obtained more than 10 years ago when malnutrition prevailed. In recent years, the impact of obesity on liver damage and carcinogenesis has grown. We attempted to elucidate the nutritional state and QOL in present cirrhotics.
METHODS: A research group supported by the Ministry of Health, Labor and Welfare of Japan recruited 294 cirrhotics between 2007 and 2011. Subjects comprised 171 males and 123 females, 158 of whom had hepatocellular carcinoma (HCC) and Child-Pugh grades A : B : C were 154:91:49. Anthropometry, blood biochemistry and indirect calorimetry were conducted, and QOL was measured using Short Form-8.
RESULTS: The mean body mass index (BMI) of all patients was 23.1 ± 3.4 kg/m(2) , and 31% showed obesity (BMI ≥ 25.0). In subjects without ascites, edema or HCC, mean BMI was 23.6 ± 3.6, and 34% had obesity. Protein malnutrition defined as serum albumin of less than 3.5 g/dL and energy malnutrition as respiratory quotient of less than 0.85 appeared in 61% and 43%, respectively, and protein-energy malnutrition (PEM) in 27% of all subjects. Among subjects without HCC, each proportion was 67%, 48% and 30%, respectively. QOL was significantly lower on all subscales than Japanese national standard values, but was similar regardless the presence or absence of HCC.
CONCLUSION: While PEM is still present in liver cirrhosis, an equal proportion has obesity in recent patients. Thus, in addition to guidelines for PEM, establishment of nutrition and exercise guidelines seems essential for obese patients with liver cirrhosis.
© 2013 The Japan Society of Hepatology.

Entities:  

Year:  2013        PMID: 23409849     DOI: 10.1111/hepr.12004

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  28 in total

Review 1.  Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances.

Authors:  Jaividhya Dasarathy; Arthur J McCullough; Srinivasan Dasarathy
Journal:  Alcohol Clin Exp Res       Date:  2017-07-11       Impact factor: 3.455

2.  Increase in the skeletal muscle mass to body fat mass ratio predicts the decline in transaminase in patients with nonalcoholic fatty liver disease.

Authors:  Naoki Mizuno; Yuya Seko; Seita Kataoka; Keiichiroh Okuda; Mitsuhiro Furuta; Masashi Takemura; Hiroyoshi Taketani; Tasuku Hara; Atsushi Umemura; Taichiro Nishikawa; Kanji Yamaguchi; Michihisa Moriguchi; Yoshito Itoh
Journal:  J Gastroenterol       Date:  2018-06-14       Impact factor: 7.527

3.  Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy.

Authors:  Hiroki Nishikawa; Norihiro Nishijima; Hirayuki Enomoto; Azusa Sakamoto; Akihiro Nasu; Hideyuki Komekado; Takashi Nishimura; Ryuichi Kita; Toru Kimura; Hiroko Iijima; Shuhei Nishiguchi; Yukio Osaki
Journal:  Oncol Lett       Date:  2017-05-31       Impact factor: 2.967

4.  Sarcopenia in a mice model of chronic liver disease: role of the ubiquitin-proteasome system and oxidative stress.

Authors:  Fabián Campos; Johanna Abrigo; Francisco Aguirre; Bruno Garcés; Marco Arrese; Saul Karpen; Daniel Cabrera; Marcelo E Andía; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Pflugers Arch       Date:  2018-06-20       Impact factor: 3.657

Review 5.  A closer look at quality of life in the hepatocellular carcinoma literature.

Authors:  Jenny L Firkins; Robin Tarter; Martha Driessnack; Lissi Hansen
Journal:  Qual Life Res       Date:  2021-02-24       Impact factor: 4.147

6.  Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.

Authors:  Soichi Iritani; Kenji Imai; Koji Takai; Tatsunori Hanai; Takayasu Ideta; Tsuneyuki Miyazaki; Atsushi Suetsugu; Makoto Shiraki; Masahito Shimizu; Hisataka Moriwaki
Journal:  J Gastroenterol       Date:  2014-05-10       Impact factor: 7.527

Review 7.  Nutrition and exercise in the management of liver cirrhosis.

Authors:  Nobuyuki Toshikuni; Tomiyasu Arisawa; Mikihiro Tsutsumi
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

8.  Calf Circumference as a Useful Predictor of Sarcopenia in Patients With Liver Diseases.

Authors:  Hiroki Nishikawa; Kazunori Yoh; Hirayuki Enomoto; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Ryo Takata; Kunihiro Hasegawa; Takashi Koriyama; Yukihisa Yuri; Takashi Nishimura; Shuhei Nishiguchi; Hiroko Iijima
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

9.  Health-promoting behaviors benefit the mental health of cirrhotic outpatients.

Authors:  Hui-Chuan Huang; Kuan-Chia Lin; Chia-Shin Wu; Nae-Fang Miao; Ming-Yao Chen
Journal:  Qual Life Res       Date:  2018-02-27       Impact factor: 4.147

10.  Systematic review of peri-operative nutritional support for patients undergoing hepatobiliary surgery.

Authors:  Yin Liu; Xiaoyan Xue
Journal:  Hepatobiliary Surg Nutr       Date:  2015-10       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.